News

Archived News

2005 2004 2003 2002 2001 2000 1999 1998 1997


12/05/03 Boston Biomedica, Inc. Announces 510(K) Clearance of its Lyme Western Blot Test Kit
11/17/03 Boston Biomedica Reports Third Quarter Operating Results
10/23/03 UNH SCIENTIST RECOGNIZED FOR EFFECTIVE USE OF NEW TECHNOLOGY
10/21/03 Panacos Pharmaceuticals Publishes Major Study Describing the Unique Mechanism of Action of its Lead HIV Drug Candidate, PA-457
10/10/03 Boston Biomedica Announces the Election by Stockholders Of R. Wayne Fritzsche and Calvin A. Saravis as Directors
08/28/03 Boston Biomedica Announces Resignation of Independent Accountants; No Disagreements with Accountants on Accounting Principles or Practices
08/15/03 Boston Biomedica Reports Improved Second Quarter Financial Results
08/15/03 /C O R R E C T I O N -- Boston Biomedica, Inc./
07/17/03 BBI Releases New West Nile Virus Control Targeted to Clinical Laboratories
07/09/03 Boston Biomedica Announces Agreement with Richard Schumacher in Executive Consulting Role
06/04/03 Boston Biomedica Awarded Tenth US Patent for Pressure Cycling Technology (PCT)
05/20/03 Boston Biomedica Announces Best Abstract Award at Clinical Ligand Assay Society's National Meeting for Research Using Pressure Cycling Technology
05/16/03 Boston Biomedica Reports First Quarter 2003 Financial Results
04/29/03 BBI Diagnostics and Ambion RNA Diagnostics Announce Cooperative Sales Agreement
03/31/03 Boston Biomedica Reports Fourth Quarter 2002 and Fiscal Year End 2002 Financial Results
03/03/03 Boston Biomedica, Inc. Adopts Shareholder Purchase Rights Plan
02/27/03 Boston Biomedica, Inc. Announces Approval to CE Mark For Its Accurun 1(R) Product Line
02/14/03 Boston Biomedica Announces Termination of CEO
01/27/03 Boston Biomedica Announces Change in Restricted Cash Position and Satisfaction of Limited Guaranty
01/15/03 Boston Biomedica Announces ISO13485 (2001) Quality Systems Certification
Contact Us
14 Norfolk Avenue
South Easton, MA 02375
(T) 508-230-1828
(F) 508-230-1829
info@pressurebiosciences.com